Construction and immunogenicity in a prime-boost regimen of a Semliki Forest virus-vectored experimental HIV clade A vaccine.

A novel, experimental subunit human immunodeficiency virus (HIV) vaccine, SFV.HIVA, was constructed. This consists of Semliki Forest virus (SFV), which is a suitable vaccine vector for use in humans, and a passenger gene encoding HIVA, which is an immunogen derived from HIV-1 clade A that is being c...

Full description

Bibliographic Details
Main Authors: Hanke, T, Barnfield, C, Wee, E, Agren, L, Samuel, R, Larke, N, Liljeström, P
Format: Journal article
Language:English
Published: 2003